Let’s look at the key reasons that are pushing Repare Therapeutics Inc (RPTX) to new highs

On Monday, Repare Therapeutics Inc (NASDAQ: RPTX) was 3.13% up from the session before settling in for the closing price of $0.90. A 52-week range for RPTX has been $0.89 – $4.29.

Healthcare Sector giant saw their annual sales surged by 1421.52% over the last five years. When this article was written, the company’s average yearly earnings per share was at -5.25%. With a float of $30.52 million, this company’s outstanding shares have now reached $42.51 million.

The firm has a total of 129 workers. Let’s measure their productivity. In terms of profitability, gross margin is 98.15%, operating margin of -174.4%, and the pretax margin is -155.19%.

Repare Therapeutics Inc (RPTX) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Repare Therapeutics Inc stocks. The insider ownership of Repare Therapeutics Inc is 28.21%, while institutional ownership is 43.02%. The most recent insider transaction that took place on Mar 12 ’25, was worth 4,099. In this transaction EVP, CHIEF MEDICAL OFFICER of this company sold 3,596 shares at a rate of $1.14, taking the stock ownership to the 227,813 shares. Before that another transaction happened on Mar 12 ’25, when Company’s EVP, CHIEF SCIENTIFIC OFFICER sold 5,611 for $1.14, making the entire transaction worth $6,397. This insider now owns 80,297 shares in total.

Repare Therapeutics Inc (RPTX) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around -5.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.52% during the next five years compared to -21.89% drop over the previous five years of trading.

Repare Therapeutics Inc (NASDAQ: RPTX) Trading Performance Indicators

You can see what Repare Therapeutics Inc (RPTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.74.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.01, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -1.75 in one year’s time.

Technical Analysis of Repare Therapeutics Inc (RPTX)

Analysing the last 5-days average volume posted by the [Repare Therapeutics Inc, RPTX], we can find that recorded value of 0.36 million was better than the volume posted last year of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 9.70%. Additionally, its Average True Range was 0.07.

During the past 100 days, Repare Therapeutics Inc’s (RPTX) raw stochastic average was set at 1.20%, which indicates a significant decrease from 19.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.29% in the past 14 days, which was lower than the 145.71% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.1341, while its 200-day Moving Average is $2.4500. Now, the first resistance to watch is $0.9421. This is followed by the second major resistance level at $0.9561. The third major resistance level sits at $0.9821. If the price goes on to break the first support level at $0.9021, it is likely to go to the next support level at $0.8761. Now, if the price goes above the second support level, the third support stands at $0.8621.

Repare Therapeutics Inc (NASDAQ: RPTX) Key Stats

There are 42,511K outstanding shares of the company, which has a market capitalization of 39.46 million. As of now, sales total 53,480 K while income totals -84,690 K. Its latest quarter income was 0 K while its last quarter net income were -34,410 K.